Literature DB >> 11372744

Tyrosine phosphorylation of proteins in primary human myeloid leukemic cells stimulated by macrophage colony-stimulating factor: analysis by disease type and comparison with normal human hematopoietic cells.

S Hagiwara1, M Yagisawa, K Saeki, S Iki, A Urabe, T Mimura, A Miwa, A Togawa, M Higashihara, F Takaku, A Yuo.   

Abstract

We investigated tyrosine phosphorylation of proteins in primary human leukemic cells stimulated by macrophage colony-stimulating factor (M-CSF) in 60 patients with acute myeloid leukemia (AML) and 5 patients with chronic myelomonocytic leukemia and compared the findings for leukemic cells with those of normal human monocytes and bone marrow immature hematopoietic cells. M-CSF induced tyrosine phosphorylation of p140-200, p110, p60, p44, and p42 frequently, and that of p95 and p55 less frequently, in primary myeloid leukemic cells, whereas M-CSF-induced phosphorylation of proteins was not detected in the normal human hematopoietic cells tested. Of these phosphoproteins, p140-200 was phosphorylated in all patients who responded to M-CSF and was considered to be almost identical to Fms, a product of the c-fms proto-oncogene. M-CSF-induced tyrosine phosphorylation was observed frequently (89%) in AML of French-American-British class M4 and infrequently in all other subtypes of AML, including M5. In chronic myelomonocytic leukemia, M-CSF-induced protein phosphorylation was prominent in blast crisis but was not detected in the chronic phase. Both bone marrow immature cells and mature monocytes showed low responsiveness to M-CSF. These findings for responsiveness to M-CSF were correlated with the amount of Fms in each type of cell. We also identified tyrosine phosphorylation of Vav, Shc, and extracellular signal-regulated kinase by M-CSF in some cases. These findings clarified an M-CSF-specific pattern of protein tyrosine phosphorylation and the responsiveness to M-CSF of primary human myeloid cells. Particularly, enhanced phosphorylation responses to M-CSF and increased amounts of Fms protein were observed in restricted human hematopoietic cells with a premature myelomonocytic character.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372744     DOI: 10.1007/bf02981910

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

1.  Expression of c-Myc in response to colony-stimulating factor-1 requires mitogen-activated protein kinase kinase-1.

Authors:  M Cheng; D Wang; M F Roussel
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

3.  cAMP enhances CSF-1-induced ERK activity and c-fos mRNA expression via a MEK-dependent and Ras-independent mechanism in macrophages.

Authors:  N J Wilson; A Jaworowski; A C Ward; J A Hamilton
Journal:  Biochem Biophys Res Commun       Date:  1998-03-17       Impact factor: 3.575

4.  FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.

Authors:  A Yen; R Sturgill; S Varvayanis; R Chern
Journal:  Exp Cell Res       Date:  1996-11-25       Impact factor: 3.905

5.  Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.

Authors:  S Hagiwara; S Iki; A Urabe; K Saeki; A Miwa; A Togawa; K Ozawa; F Takaku; A Yuo
Journal:  Int J Hematol       Date:  1998-12       Impact factor: 2.490

6.  Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts.

Authors:  U Novak; A G Harpur; L Paradiso; V Kanagasundaram; A Jaworowski; A F Wilks; J A Hamilton
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

7.  Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages.

Authors:  Y G Yeung; Y Wang; D B Einstein; P S Lee; E R Stanley
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

8.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

9.  Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists.

Authors:  A Yuo; S Kitagawa; K Motoyoshi; E Azuma; M Saito; F Takaku
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

10.  Cell surface expression of v-fms-coded glycoproteins is required for transformation.

Authors:  M F Roussel; C W Rettenmier; A T Look; C J Sherr
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

View more
  1 in total

1.  Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.

Authors:  Shulamit Sebban; Marganit Farago; Shiran Rabinovich; Galit Lazer; Yulia Idelchuck; Lena Ilan; Eli Pikarsky; Shulamit Katzav
Journal:  Oncotarget       Date:  2014-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.